<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-02-01" modified="2020-08-12" version="212">
<accession>P20813</accession>
<accession>B4DWP3</accession>
<accession>Q2V565</accession>
<accession>Q9UK46</accession>
<name>CP2B6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cytochrome P450 2B6</fullName>
<ecNumber evidence="11 19">1.14.13.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="24">1,4-cineole 2-exo-monooxygenase</fullName>
</alternativeName>
<alternativeName>
<fullName>CYPIIB6</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="27">Cytochrome P450 IIB1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="26 31">CYP2B6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Biochemistry" volume="28" first="7340" last="7348">
<title>cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver.</title>
<authorList>
<person name="Yamano S."/>
<person name="Nhamburo P.T."/>
<person name="Aoyama T."/>
<person name="Meyer U.A."/>
<person name="Inaba T."/>
<person name="Kalow W."/>
<person name="Gelboin H.V."/>
<person name="McBride O.W."/>
<person name="Gonzalez F.J."/>
</authorList>
<dbReference type="PubMed" id="2573390"/>
<dbReference type="DOI" id="10.1021/bi00444a029"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1999-09" db="EMBL/GenBank/DDBJ databases">
<title>Sequence of a new human cytochrome P450-2B6 cDNA.</title>
<authorList>
<person name="Zhuge J."/>
<person name="Qian Y."/>
<person name="Xie H."/>
<person name="Yu Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS ALA-167; HIS-172 AND ARG-262</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS CYS-22; SER-26; GLY-28; SER-29; HIS-172; ARG-262; LYS-289; SER-306; THR-328 AND CYS-487</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="8241" last="8255">
<title>Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages.</title>
<authorList>
<person name="Miles J.S."/>
<person name="McLaren A.W."/>
<person name="Wolf C.R."/>
</authorList>
<dbReference type="PubMed" id="2813061"/>
<dbReference type="DOI" id="10.1093/nar/17.20.8241"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 26-491 (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Lancet" volume="355" first="979" last="983">
<title>Gene expression in distinct regions of the heart.</title>
<authorList>
<person name="Thum T."/>
<person name="Borlak J."/>
</authorList>
<dbReference type="PubMed" id="10768437"/>
<dbReference type="DOI" id="10.1016/s0140-6736(00)99016-0"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Xenobiotica" volume="31" first="713" last="723">
<title>Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.</title>
<authorList>
<person name="Miyazawa M."/>
<person name="Shindo M."/>
<person name="Shimada T."/>
</authorList>
<dbReference type="PubMed" id="11695850"/>
<dbReference type="DOI" id="10.1080/00498250110065595"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION AS 1,4-CINEOLE 2-EXO-MONOOXYGENASE</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Endocrinology" volume="144" first="3382" last="3398">
<title>Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.</title>
<authorList>
<person name="Lee A.J."/>
<person name="Cai M.X."/>
<person name="Thomas P.E."/>
<person name="Conney A.H."/>
<person name="Zhu B.T."/>
</authorList>
<dbReference type="PubMed" id="12865317"/>
<dbReference type="DOI" id="10.1210/en.2003-0192"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="Drug Metab. Dispos." volume="39" first="782" last="788">
<title>Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.</title>
<authorList>
<person name="Sridar C."/>
<person name="Snider N.T."/>
<person name="Hollenberg P.F."/>
</authorList>
<dbReference type="PubMed" id="21289075"/>
<dbReference type="DOI" id="10.1124/dmd.110.036707"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Mol. Pharmacol." volume="77" first="529" last="538">
<title>Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution.</title>
<authorList>
<person name="Gay S.C."/>
<person name="Shah M.B."/>
<person name="Talakad J.C."/>
<person name="Maekawa K."/>
<person name="Roberts A.G."/>
<person name="Wilderman P.R."/>
<person name="Sun L."/>
<person name="Yang J.Y."/>
<person name="Huelga S.C."/>
<person name="Hong W.X."/>
<person name="Zhang Q."/>
<person name="Stout C.D."/>
<person name="Halpert J.R."/>
</authorList>
<dbReference type="PubMed" id="20061448"/>
<dbReference type="DOI" id="10.1124/mol.109.062570"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 30-491 OF VARIANT ARG-262 IN COMPLEX WITH HEME AND SYNTHETIC INHIBITOR</scope>
<scope>COFACTOR</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="Mol. Pharmacol." volume="80" first="1047" last="1055">
<title>Structures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl)pyridine: insight into inhibitor binding and rearrangement of active site side chains.</title>
<authorList>
<person name="Shah M.B."/>
<person name="Pascual J."/>
<person name="Zhang Q."/>
<person name="Stout C.D."/>
<person name="Halpert J.R."/>
</authorList>
<dbReference type="PubMed" id="21875942"/>
<dbReference type="DOI" id="10.1124/mol.111.074427"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 30-491 OF VARIANT ARG-262 IN COMPLEX WITH HEME AND SYNTHETIC INHIBITOR</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2012" name="Biochemistry" volume="51" first="7225" last="7238">
<title>Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.</title>
<authorList>
<person name="Shah M.B."/>
<person name="Wilderman P.R."/>
<person name="Pascual J."/>
<person name="Zhang Q."/>
<person name="Stout C.D."/>
<person name="Halpert J.R."/>
</authorList>
<dbReference type="PubMed" id="22909231"/>
<dbReference type="DOI" id="10.1021/bi300894z"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 30-491 IN COMPLEX WITH HEME AND AMLODIPINE</scope>
<scope>FUNCTION</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="AIDS" volume="18" first="2391" last="2400">
<title>Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.</title>
<authorList>
<person name="Haas D.W."/>
<person name="Ribaudo H.J."/>
<person name="Kim R.B."/>
<person name="Tierney C."/>
<person name="Wilkinson G.R."/>
<person name="Gulick R.M."/>
<person name="Clifford D.B."/>
<person name="Hulgan T."/>
<person name="Marzolini C."/>
<person name="Acosta E.P."/>
</authorList>
<dbReference type="PubMed" id="15622315"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN EFAVIRENZ POOR METABOLISM</scope>
<scope>SUSCEPTIBILITY TO EFAVIRENZ TOXICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="319" first="1322" last="1326">
<title>Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.</title>
<authorList>
<person name="Tsuchiya K."/>
<person name="Gatanaga H."/>
<person name="Tachikawa N."/>
<person name="Teruya K."/>
<person name="Kikuchi Y."/>
<person name="Yoshino M."/>
<person name="Kuwahara T."/>
<person name="Shirasaka T."/>
<person name="Kimura S."/>
<person name="Oka S."/>
</authorList>
<dbReference type="PubMed" id="15194512"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.05.116"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN EFAVIRENZ POOR METABOLISM</scope>
<scope>SUSCEPTIBILITY TO EFAVIRENZ TOXICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="J. Antimicrob. Chemother." volume="65" first="1889" last="1893">
<title>Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort.</title>
<authorList>
<person name="Carr D.F."/>
<person name="la Porte C.J."/>
<person name="Pirmohamed M."/>
<person name="Owen A."/>
<person name="Cortes C.P."/>
</authorList>
<dbReference type="PubMed" id="20639527"/>
<dbReference type="DOI" id="10.1093/jac/dkq260"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN EFAVIRENZ POOR METABOLISM</scope>
<scope>SUSCEPTIBILITY TO EFAVIRENZ TOXICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Pharmacogenomics" volume="11" first="1223" last="1234">
<title>Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.</title>
<authorList>
<person name="Elens L."/>
<person name="Vandercam B."/>
<person name="Yombi J.C."/>
<person name="Lison D."/>
<person name="Wallemacq P."/>
<person name="Haufroid V."/>
</authorList>
<dbReference type="PubMed" id="20860463"/>
<dbReference type="DOI" id="10.2217/pgs.10.94"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN EFAVIRENZ POOR METABOLISM</scope>
<scope>SUSCEPTIBILITY TO EFAVIRENZ TOXICITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="281" first="1256" last="1260">
<title>A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation.</title>
<authorList>
<person name="Ariyoshi N."/>
<person name="Miyazaki M."/>
<person name="Toide K."/>
<person name="Sawamura Y.I."/>
<person name="Kamataki T."/>
</authorList>
<dbReference type="PubMed" id="11243870"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.4524"/>
</citation>
<scope>VARIANT HIS-172</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Pharmacogenetics" volume="11" first="399" last="415">
<title>Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.</title>
<authorList>
<person name="Lang T."/>
<person name="Klein K."/>
<person name="Fischer J."/>
<person name="Nussler A.K."/>
<person name="Neuhaus P."/>
<person name="Hofmann U."/>
<person name="Eichelbaum M."/>
<person name="Schwab M."/>
<person name="Zanger U.M."/>
</authorList>
<dbReference type="PubMed" id="11470993"/>
<dbReference type="DOI" id="10.1097/00008571-200107000-00004"/>
</citation>
<scope>VARIANTS CYS-22; HIS-172; ARG-259; ARG-262 AND CYS-487</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Drug Metab. Dispos." volume="31" first="398" last="403">
<title>Functional characterization of cytochrome P450 2B6 allelic variants.</title>
<authorList>
<person name="Jinno H."/>
<person name="Tanaka-Kagawa T."/>
<person name="Ohno A."/>
<person name="Makino Y."/>
<person name="Matsushima E."/>
<person name="Hanioka N."/>
<person name="Ando M."/>
</authorList>
<dbReference type="PubMed" id="12642465"/>
<dbReference type="DOI" id="10.1124/dmd.31.4.398"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CYS-22; HIS-172; ARG-259; ARG-262 AND CYS-487</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="249" last="270">
<title>Catalog of 680 variations among eight cytochrome p450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population.</title>
<authorList>
<person name="Saito S."/>
<person name="Iida A."/>
<person name="Sekine A."/>
<person name="Kawauchi S."/>
<person name="Higuchi S."/>
<person name="Ogawa C."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="12721789"/>
<dbReference type="DOI" id="10.1007/s10038-003-0021-7"/>
</citation>
<scope>VARIANTS CYS-22; ALA-167; HIS-172 AND CYS-487</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Pharmacol. Exp. Ther." volume="307" first="906" last="922">
<title>Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.</title>
<authorList>
<person name="Lamba V."/>
<person name="Lamba J."/>
<person name="Yasuda K."/>
<person name="Strom S."/>
<person name="Davila J."/>
<person name="Hancock M.L."/>
<person name="Fackenthal J.D."/>
<person name="Rogan P.K."/>
<person name="Ring B."/>
<person name="Wrighton S.A."/>
<person name="Schuetz E.G."/>
</authorList>
<dbReference type="PubMed" id="14551287"/>
<dbReference type="DOI" id="10.1124/jpet.103.054866"/>
</citation>
<scope>VARIANTS CYS-22; GLU-139; HIS-172 AND CYS-487</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="J. Pharmacol. Exp. Ther." volume="311" first="34" last="43">
<title>Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles.</title>
<authorList>
<person name="Lang T."/>
<person name="Klein K."/>
<person name="Richter T."/>
<person name="Zibat A."/>
<person name="Kerb R."/>
<person name="Eichelbaum M."/>
<person name="Schwab M."/>
<person name="Zanger U.M."/>
</authorList>
<dbReference type="PubMed" id="15190123"/>
<dbReference type="DOI" id="10.1124/jpet.104.068973"/>
</citation>
<scope>VARIANTS LEU-21; VAL-46; GLU-99; GLU-139; GLN-140 AND ASN-391</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Pharmacogenomics" volume="5" first="895" last="931">
<title>Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.</title>
<authorList>
<person name="Solus J.F."/>
<person name="Arietta B.J."/>
<person name="Harris J.R."/>
<person name="Sexton D.P."/>
<person name="Steward J.Q."/>
<person name="McMunn C."/>
<person name="Ihrie P."/>
<person name="Mehall J.M."/>
<person name="Edwards T.L."/>
<person name="Dawson E.P."/>
</authorList>
<dbReference type="PubMed" id="15469410"/>
<dbReference type="DOI" id="10.1517/14622416.5.7.895"/>
</citation>
<scope>VARIANTS CYS-22; HIS-172; ARG-262; THR-328 AND CYS-487</scope>
</reference>
<comment type="function">
<text evidence="8 11 19 21">A cytochrome P450 monooxygenase involved in the metabolism of endocannabinoids and steroids (PubMed:21289075, PubMed:12865317). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:21289075). Hydroxylates steroid hormones, including testosterone at C-16 and estrogens at C-2 (PubMed:21289075, PubMed:12865317). Plays a role in the oxidative metabolism of xenobiotics, including plant lipids and drugs (PubMed:11695850, PubMed:22909231). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850).</text>
</comment>
<comment type="function">
<text evidence="19">Allele 2B6*9: Has low affinity for anandamide and can only produce 11,12 EpETrE-EAs.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced [NADPH--hemoprotein reductase] = H(+) + H2O + N-(14,15-epoxy-5Z,8Z,11Z-eicosatrienoyl)-ethanolamine + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53148"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:2700"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:136991"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:53149"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced [NADPH--hemoprotein reductase] = H(+) + H2O + N-(11,12-epoxy-5Z,8Z,14Z-eicosatrienoyl)-ethanolamine + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53144"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:2700"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:136990"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:53145"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine + O2 + reduced [NADPH--hemoprotein reductase] = H(+) + H2O + N-(8,9-epoxy-5Z,11Z,14Z-eicosatrienoyl)-ethanolamine + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53140"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:2700"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:136989"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:53141"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>O2 + reduced [NADPH--hemoprotein reductase] + testosterone = 16alpha,17beta-dihydroxyandrost-4-en-3-one + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53196"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17347"/>
<dbReference type="ChEBI" id="CHEBI:34172"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:53197"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>O2 + reduced [NADPH--hemoprotein reductase] + testosterone = 16beta,17beta-dihydroxyandrost-4-en-3-one + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:46304"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17347"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:83027"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:46305"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="11">
<text>17beta-estradiol + O2 + reduced [NADPH--hemoprotein reductase] = 2-hydroxy-17beta-estradiol + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:47212"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:16469"/>
<dbReference type="ChEBI" id="CHEBI:28744"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:47213"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="11">
<text>estrone + O2 + reduced [NADPH--hemoprotein reductase] = 2-hydroxyestrone + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:47208"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:1156"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17263"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:47209"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>1,4-cineole + O2 + reduced [NADPH--hemoprotein reductase] = 2-exo-hydroxy-1,4-cineole + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:49160"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:80788"/>
<dbReference type="ChEBI" id="CHEBI:90956"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="29">
<dbReference type="Rhea" id="RHEA:49161"/>
</physiologicalReaction>
</comment>
<comment type="cofactor">
<cofactor evidence="17 20 21">
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="8">360 uM for 1,4-cineole</KM>
<KM evidence="19">13.3 uM for testosterone (16-alpha-hydroxylation)</KM>
<KM evidence="19">27.7 uM for testosterone (16-beta-hydroxylation)</KM>
<KM evidence="19">3.6 uM for N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine (14,15-epoxidation)</KM>
<KM evidence="19">1.32 uM for N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine (11,12-epoxidation)</KM>
<KM evidence="19">1.21 uM for N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine (8,9-epoxidation)</KM>
<Vmax evidence="8">3.4 nmol/min/nmol enzyme toward 1,4-cineole</Vmax>
<Vmax evidence="19">2.04 pmol/min/pmol enzyme toward N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine (14,15-epoxidation)</Vmax>
<Vmax evidence="19">7.56 pmol/min/pmol enzyme toward N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine (11,12-epoxidation)</Vmax>
<Vmax evidence="19">3.12 pmol/min/pmol enzyme toward N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine (8,9-epoxidation)</Vmax>
</kinetics>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Microsome membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P20813-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P20813-2</id>
<name>2</name>
<sequence type="described" ref="VSP_055571 VSP_055572"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="5">Expressed in liver, lung and heart right ventricle.</text>
</comment>
<comment type="induction">
<text>By phenobarbital.</text>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylation is accompanied by a decrease in enzyme activity.</text>
</comment>
<comment type="polymorphism">
<text evidence="14 16 18 19">Variability among CYP2B6 alleles may account for differential metabolism of endogenous steroids and endocannabinoids among individuals. For 16-alpha hydroxylation of testosterone, Vmax/Km values between alleles decrease in the following order: 2B6*1 &gt; 2B6*6 &gt; 2B6*9 &gt; 2B7*4. For 16-beta hydroxylation of testosterone, 2B6*6 has the highest catalytic efficiency. For anandamide metabolism, 2B6*6 and 2B6*9 alleles show significantly lower rates of epoxidation (PubMed:21289075). Genetic variations in CYP2B6 are responsible for poor metabolism of efavirenz and, therefore, susceptibility to efavirenz toxicity in the central nervous system [MIM:614546]. Efavirenz is a non-nucleoside reverse transcriptase inhibitor frequently prescribed with 2 nucleoside reverse transcriptase inhibitors as initial therapy for human immunodeficiency virus (HIV) infection. Up to half of patients treated with efavirenz, experience side effects in the central nervous system, including dizziness, insomnia, impaired concentration, somnolence, and abnormal dreams. Severe depression, aggressive behavior, and paranoid or manic reactions may also occur, depending on efavirenz concentration in the plasma. Patients homozygous for 2B6*6 have significantly higher plasma efavirenz levels when compared to 2B6*6 heterozygous ones (PubMed:15622315, PubMed:15194512, PubMed:20639527).</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the cytochrome P450 family.</text>
</comment>
<comment type="online information" name="Cytochrome P450 Allele Nomenclature Committee">
<link uri="http://www.cypalleles.ki.se/cyp2b6.htm"/>
<text>CYP2B6 alleles</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cyp2b6/"/>
</comment>
<dbReference type="EC" id="1.14.13.-" evidence="11 19"/>
<dbReference type="EMBL" id="M29874">
<property type="protein sequence ID" value="AAA52144.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF182277">
<property type="protein sequence ID" value="AAF13602.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK301620">
<property type="protein sequence ID" value="BAG63105.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ298753">
<property type="protein sequence ID" value="ABB84469.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC023172">
<property type="protein sequence ID" value="AAF32444.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011541">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X13494">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12570.1">
<molecule id="P20813-1"/>
</dbReference>
<dbReference type="PIR" id="A32969">
<property type="entry name" value="A32969"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000758.1">
<molecule id="P20813-1"/>
<property type="nucleotide sequence ID" value="NM_000767.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011524852.1">
<property type="nucleotide sequence ID" value="XM_011526550.2"/>
</dbReference>
<dbReference type="PDB" id="3IBD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=30-491"/>
</dbReference>
<dbReference type="PDB" id="3QOA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=27-491"/>
</dbReference>
<dbReference type="PDB" id="3QU8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D/E/F=27-491"/>
</dbReference>
<dbReference type="PDB" id="3UA5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=27-491"/>
</dbReference>
<dbReference type="PDB" id="4I91">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=27-491"/>
</dbReference>
<dbReference type="PDB" id="4RQL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=27-491"/>
</dbReference>
<dbReference type="PDB" id="4RRT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=27-491"/>
</dbReference>
<dbReference type="PDB" id="4ZV8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.24"/>
<property type="chains" value="A=30-491"/>
</dbReference>
<dbReference type="PDB" id="5UAP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A/B=20-491"/>
</dbReference>
<dbReference type="PDB" id="5UDA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A/B=20-491"/>
</dbReference>
<dbReference type="PDB" id="5UEC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A=20-491"/>
</dbReference>
<dbReference type="PDB" id="5UFG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A=20-491"/>
</dbReference>
<dbReference type="PDB" id="5WBG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B/C/D/E/F=20-491"/>
</dbReference>
<dbReference type="PDBsum" id="3IBD"/>
<dbReference type="PDBsum" id="3QOA"/>
<dbReference type="PDBsum" id="3QU8"/>
<dbReference type="PDBsum" id="3UA5"/>
<dbReference type="PDBsum" id="4I91"/>
<dbReference type="PDBsum" id="4RQL"/>
<dbReference type="PDBsum" id="4RRT"/>
<dbReference type="PDBsum" id="4ZV8"/>
<dbReference type="PDBsum" id="5UAP"/>
<dbReference type="PDBsum" id="5UDA"/>
<dbReference type="PDBsum" id="5UEC"/>
<dbReference type="PDBsum" id="5UFG"/>
<dbReference type="PDBsum" id="5WBG"/>
<dbReference type="SMR" id="P20813"/>
<dbReference type="BioGRID" id="107933">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="IntAct" id="P20813">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000324648"/>
<dbReference type="BindingDB" id="P20813"/>
<dbReference type="ChEMBL" id="CHEMBL4729"/>
<dbReference type="DrugBank" id="DB08369">
<property type="generic name" value="1-(biphenyl-4-ylmethyl)-1H-imidazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB02974">
<property type="generic name" value="4-(4-Chlorophenyl)Imidazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB12001">
<property type="generic name" value="Abemaciclib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00321">
<property type="generic name" value="Amitriptyline"/>
</dbReference>
<dbReference type="DrugBank" id="DB00381">
<property type="generic name" value="Amlodipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00701">
<property type="generic name" value="Amprenavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB01435">
<property type="generic name" value="Antipyrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06413">
<property type="generic name" value="Armodafinil"/>
</dbReference>
<dbReference type="DrugBank" id="DB06697">
<property type="generic name" value="Artemether"/>
</dbReference>
<dbReference type="DrugBank" id="DB13132">
<property type="generic name" value="Artemisinin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11586">
<property type="generic name" value="Asunaprevir"/>
</dbReference>
<dbReference type="DrugBank" id="DB01076">
<property type="generic name" value="Atorvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00972">
<property type="generic name" value="Azelastine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04975">
<property type="generic name" value="Banoxantrone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00865">
<property type="generic name" value="Benzphetamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00443">
<property type="generic name" value="Betamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04794">
<property type="generic name" value="Bifonazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB05541">
<property type="generic name" value="Brivaracetam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01222">
<property type="generic name" value="Budesonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01156">
<property type="generic name" value="Bupropion"/>
</dbReference>
<dbReference type="DrugBank" id="DB00564">
<property type="generic name" value="Carbamazepine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06119">
<property type="generic name" value="Cenobamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00439">
<property type="generic name" value="Cerivastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00568">
<property type="generic name" value="Cinnarizine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00604">
<property type="generic name" value="Cisapride"/>
</dbReference>
<dbReference type="DrugBank" id="DB00515">
<property type="generic name" value="Cisplatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00349">
<property type="generic name" value="Clobazam"/>
</dbReference>
<dbReference type="DrugBank" id="DB06470">
<property type="generic name" value="Clomethiazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00758">
<property type="generic name" value="Clopidogrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB01559">
<property type="generic name" value="Clotiazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00257">
<property type="generic name" value="Clotrimazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB01394">
<property type="generic name" value="Colchicine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05219">
<property type="generic name" value="Crisaborole"/>
</dbReference>
<dbReference type="DrugBank" id="DB08865">
<property type="generic name" value="Crizotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11672">
<property type="generic name" value="Curcumin"/>
</dbReference>
<dbReference type="DrugBank" id="DB14635">
<property type="generic name" value="Curcumin sulfate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04664">
<property type="generic name" value="Cyclohexyl-pentyl-maltoside"/>
</dbReference>
<dbReference type="DrugBank" id="DB00531">
<property type="generic name" value="Cyclophosphamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08912">
<property type="generic name" value="Dabrafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01151">
<property type="generic name" value="Desipramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01234">
<property type="generic name" value="Dexamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04856">
<property type="generic name" value="Dexloxiglumide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00514">
<property type="generic name" value="Dextromethorphan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00829">
<property type="generic name" value="Diazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00586">
<property type="generic name" value="Diclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB01184">
<property type="generic name" value="Domperidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00997">
<property type="generic name" value="Doxorubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00625">
<property type="generic name" value="Efavirenz"/>
</dbReference>
<dbReference type="DrugBank" id="DB15444">
<property type="generic name" value="Elexacaftor"/>
</dbReference>
<dbReference type="DrugBank" id="DB13874">
<property type="generic name" value="Enasidenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08899">
<property type="generic name" value="Enzalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00751">
<property type="generic name" value="Epinastine"/>
</dbReference>
<dbReference type="DrugBank" id="DB11823">
<property type="generic name" value="Esketamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00655">
<property type="generic name" value="Estrone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00898">
<property type="generic name" value="Ethanol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01466">
<property type="generic name" value="Ethylmorphine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01544">
<property type="generic name" value="Flunitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00472">
<property type="generic name" value="Fluoxetine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01095">
<property type="generic name" value="Fluvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00176">
<property type="generic name" value="Fluvoxamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01320">
<property type="generic name" value="Fosphenytoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01159">
<property type="generic name" value="Halothane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00956">
<property type="generic name" value="Hydrocodone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00741">
<property type="generic name" value="Hydrocortisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09054">
<property type="generic name" value="Idelalisib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01181">
<property type="generic name" value="Ifosfamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00458">
<property type="generic name" value="Imipramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00762">
<property type="generic name" value="Irinotecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB11633">
<property type="generic name" value="Isavuconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00753">
<property type="generic name" value="Isoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB11757">
<property type="generic name" value="Istradefylline"/>
</dbReference>
<dbReference type="DrugBank" id="DB01167">
<property type="generic name" value="Itraconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB14568">
<property type="generic name" value="Ivosidenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09570">
<property type="generic name" value="Ixazomib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01221">
<property type="generic name" value="Ketamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06738">
<property type="generic name" value="Ketobemidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB11951">
<property type="generic name" value="Lemborexant"/>
</dbReference>
<dbReference type="DrugBank" id="DB09078">
<property type="generic name" value="Lenvatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB12070">
<property type="generic name" value="Letermovir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00281">
<property type="generic name" value="Lidocaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00836">
<property type="generic name" value="Loperamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01601">
<property type="generic name" value="Lopinavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00455">
<property type="generic name" value="Loratadine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04871">
<property type="generic name" value="Lorcaserin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12130">
<property type="generic name" value="Lorlatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09280">
<property type="generic name" value="Lumacaftor"/>
</dbReference>
<dbReference type="DrugBank" id="DB00772">
<property type="generic name" value="Malathion"/>
</dbReference>
<dbReference type="DrugBank" id="DB09238">
<property type="generic name" value="Manidipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01043">
<property type="generic name" value="Memantine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00454">
<property type="generic name" value="Meperidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00532">
<property type="generic name" value="Mephenytoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04817">
<property type="generic name" value="Metamizole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00333">
<property type="generic name" value="Methadone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00763">
<property type="generic name" value="Methimazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB01028">
<property type="generic name" value="Methoxyflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB09241">
<property type="generic name" value="Methylene blue"/>
</dbReference>
<dbReference type="DrugBank" id="DB00849">
<property type="generic name" value="Methylphenobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00959">
<property type="generic name" value="Methylprednisolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06710">
<property type="generic name" value="Methyltestosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00379">
<property type="generic name" value="Mexiletine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06148">
<property type="generic name" value="Mianserin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01110">
<property type="generic name" value="Miconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB06595">
<property type="generic name" value="Midostaurin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00745">
<property type="generic name" value="Modafinil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00220">
<property type="generic name" value="Nelfinavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00238">
<property type="generic name" value="Nevirapine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00622">
<property type="generic name" value="Nicardipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00184">
<property type="generic name" value="Nicotine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01115">
<property type="generic name" value="Nifedipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04868">
<property type="generic name" value="Nilotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00435">
<property type="generic name" value="Nitric Oxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00957">
<property type="generic name" value="Norgestimate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09074">
<property type="generic name" value="Olaparib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01173">
<property type="generic name" value="Orphenadrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB11837">
<property type="generic name" value="Osilodrostat"/>
</dbReference>
<dbReference type="DrugBank" id="DB04938">
<property type="generic name" value="Ospemifene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00715">
<property type="generic name" value="Paroxetine"/>
</dbReference>
<dbReference type="DrugBank" id="DB08883">
<property type="generic name" value="Perampanel"/>
</dbReference>
<dbReference type="DrugBank" id="DB01074">
<property type="generic name" value="Perhexiline"/>
</dbReference>
<dbReference type="DrugBank" id="DB04930">
<property type="generic name" value="Permethrin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12978">
<property type="generic name" value="Pexidartinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB03575">
<property type="generic name" value="Phencyclidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01174">
<property type="generic name" value="Phenobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00252">
<property type="generic name" value="Phenytoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB13941">
<property type="generic name" value="Piperaquine"/>
</dbReference>
<dbReference type="DrugBank" id="DB11642">
<property type="generic name" value="Pitolisant"/>
</dbReference>
<dbReference type="DrugBank" id="DB06209">
<property type="generic name" value="Prasugrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB14631">
<property type="generic name" value="Prednisolone phosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00635">
<property type="generic name" value="Prednisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01069">
<property type="generic name" value="Promethazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00818">
<property type="generic name" value="Propofol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01589">
<property type="generic name" value="Quazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00908">
<property type="generic name" value="Quinidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00481">
<property type="generic name" value="Raloxifene"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00615">
<property type="generic name" value="Rifabutin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01045">
<property type="generic name" value="Rifampicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11753">
<property type="generic name" value="Rifamycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01201">
<property type="generic name" value="Rifapentine"/>
</dbReference>
<dbReference type="DrugBank" id="DB08864">
<property type="generic name" value="Rilpivirine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00503">
<property type="generic name" value="Ritonavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB06176">
<property type="generic name" value="Romidepsin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00296">
<property type="generic name" value="Ropivacaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00778">
<property type="generic name" value="Roxithromycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB06654">
<property type="generic name" value="Safinamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01037">
<property type="generic name" value="Selegiline"/>
</dbReference>
<dbReference type="DrugBank" id="DB06739">
<property type="generic name" value="Seratrodast"/>
</dbReference>
<dbReference type="DrugBank" id="DB01104">
<property type="generic name" value="Sertraline"/>
</dbReference>
<dbReference type="DrugBank" id="DB01236">
<property type="generic name" value="Sevoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00641">
<property type="generic name" value="Simvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06729">
<property type="generic name" value="Sulfaphenazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB01138">
<property type="generic name" value="Sulfinpyrazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00231">
<property type="generic name" value="Temazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00624">
<property type="generic name" value="Testosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB13943">
<property type="generic name" value="Testosterone cypionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13944">
<property type="generic name" value="Testosterone enanthate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13946">
<property type="generic name" value="Testosterone undecanoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04572">
<property type="generic name" value="Thiotepa"/>
</dbReference>
<dbReference type="DrugBank" id="DB00208">
<property type="generic name" value="Ticlopidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00193">
<property type="generic name" value="Tramadol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00755">
<property type="generic name" value="Tretinoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12245">
<property type="generic name" value="Triclabendazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB12808">
<property type="generic name" value="Trifarotene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00197">
<property type="generic name" value="Troglitazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00313">
<property type="generic name" value="Valproic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB11613">
<property type="generic name" value="Velpatasvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB08881">
<property type="generic name" value="Vemurafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00661">
<property type="generic name" value="Verapamil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00582">
<property type="generic name" value="Voriconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB09068">
<property type="generic name" value="Vortioxetine"/>
</dbReference>
<dbReference type="DrugBank" id="DB14975">
<property type="generic name" value="Voxelotor"/>
</dbReference>
<dbReference type="DrugBank" id="DB15035">
<property type="generic name" value="Zanubrutinib"/>
</dbReference>
<dbReference type="DrugCentral" id="P20813"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1324"/>
<dbReference type="SwissLipids" id="SLP:000001346"/>
<dbReference type="iPTMnet" id="P20813"/>
<dbReference type="PhosphoSitePlus" id="P20813"/>
<dbReference type="BioMuta" id="CYP2B6"/>
<dbReference type="DMDM" id="117205"/>
<dbReference type="EPD" id="P20813"/>
<dbReference type="MassIVE" id="P20813"/>
<dbReference type="PaxDb" id="P20813"/>
<dbReference type="PeptideAtlas" id="P20813"/>
<dbReference type="PRIDE" id="P20813"/>
<dbReference type="ProteomicsDB" id="5366"/>
<dbReference type="ProteomicsDB" id="53803">
<molecule id="P20813-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="30684">
<property type="antibodies" value="334 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000324071">
<molecule id="P20813-1"/>
<property type="protein sequence ID" value="ENSP00000324648"/>
<property type="gene ID" value="ENSG00000197408"/>
</dbReference>
<dbReference type="GeneID" id="1555"/>
<dbReference type="KEGG" id="hsa:1555"/>
<dbReference type="UCSC" id="uc002opr.2">
<molecule id="P20813-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1555"/>
<dbReference type="DisGeNET" id="1555"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197408.8"/>
<dbReference type="GeneCards" id="CYP2B6"/>
<dbReference type="HGNC" id="HGNC:2615">
<property type="gene designation" value="CYP2B6"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000197408">
<property type="expression patterns" value="Tissue enriched (liver)"/>
</dbReference>
<dbReference type="MalaCards" id="CYP2B6"/>
<dbReference type="MIM" id="123930">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614546">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P20813"/>
<dbReference type="OpenTargets" id="ENSG00000197408"/>
<dbReference type="Orphanet" id="240869">
<property type="disease" value="Efavirenz toxicity"/>
</dbReference>
<dbReference type="PharmGKB" id="PA123"/>
<dbReference type="eggNOG" id="KOG0156">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157162"/>
<dbReference type="HOGENOM" id="CLU_001570_22_3_1"/>
<dbReference type="InParanoid" id="P20813"/>
<dbReference type="KO" id="K17709"/>
<dbReference type="OMA" id="HICLGMK"/>
<dbReference type="OrthoDB" id="702827at2759"/>
<dbReference type="PhylomeDB" id="P20813"/>
<dbReference type="TreeFam" id="TF352043"/>
<dbReference type="BioCyc" id="MetaCyc:HS09587-MONOMER"/>
<dbReference type="BRENDA" id="1.14.14.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P20813"/>
<dbReference type="Reactome" id="R-HSA-211935">
<property type="pathway name" value="Fatty acids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211981">
<property type="pathway name" value="Xenobiotics"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211999">
<property type="pathway name" value="CYP2E1 reactions"/>
</dbReference>
<dbReference type="SABIO-RK" id="P20813"/>
<dbReference type="SIGNOR" id="P20813"/>
<dbReference type="BioGRID-ORCS" id="1555">
<property type="hits" value="4 hits in 868 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P20813"/>
<dbReference type="GeneWiki" id="CYP2B6"/>
<dbReference type="GenomeRNAi" id="1555"/>
<dbReference type="Pharos" id="P20813">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P20813"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P20813">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197408">
<property type="expression patterns" value="Expressed in liver and 92 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P20813">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P20813">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0062188">
<property type="term" value="F:anandamide 11,12 epoxidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0062189">
<property type="term" value="F:anandamide 14,15 epoxidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0062187">
<property type="term" value="F:anandamide 8,9 epoxidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008392">
<property type="term" value="F:arachidonic acid epoxygenase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0101021">
<property type="term" value="F:estrogen 2-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004497">
<property type="term" value="F:monooxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016712">
<property type="term" value="F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008395">
<property type="term" value="F:steroid hydroxylase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008390">
<property type="term" value="F:testosterone 16-alpha-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0062184">
<property type="term" value="F:testosterone 16-beta-hydroxylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042180">
<property type="term" value="P:cellular ketone metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017144">
<property type="term" value="P:drug metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019373">
<property type="term" value="P:epoxygenase P450 pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042738">
<property type="term" value="P:exogenous drug catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006082">
<property type="term" value="P:organic acid metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0055114">
<property type="term" value="P:oxidation-reduction process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008202">
<property type="term" value="P:steroid metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006805">
<property type="term" value="P:xenobiotic metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001128">
<property type="entry name" value="Cyt_P450"/>
</dbReference>
<dbReference type="InterPro" id="IPR017972">
<property type="entry name" value="Cyt_P450_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002401">
<property type="entry name" value="Cyt_P450_E_grp-I"/>
</dbReference>
<dbReference type="InterPro" id="IPR008068">
<property type="entry name" value="Cyt_P450_E_grp-I_CYP2B-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036396">
<property type="entry name" value="Cyt_P450_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00067">
<property type="entry name" value="p450"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00463">
<property type="entry name" value="EP450I"/>
</dbReference>
<dbReference type="PRINTS" id="PR01685">
<property type="entry name" value="EP450ICYP2B"/>
</dbReference>
<dbReference type="PRINTS" id="PR00385">
<property type="entry name" value="P450"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48264">
<property type="entry name" value="SSF48264"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00086">
<property type="entry name" value="CYTOCHROME_P450"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0503">Monooxygenase</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Cytochrome P450 2B6" id="PRO_0000051683">
<location>
<begin position="1"/>
<end position="491"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="4">
<location>
<position position="128"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_055571" evidence="25">
<original>MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLR</original>
<variation>MRCMLTNSHPWCGCDWQ</variation>
<location>
<begin position="1"/>
<end position="57"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_055572" evidence="25">
<location>
<begin position="162"/>
<end position="321"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*10; dbSNP:rs34883432." id="VAR_023563" evidence="13">
<original>Q</original>
<variation>L</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*2 and allele CYP2B6*10; dbSNP:rs8192709." id="VAR_016927" evidence="7 9 10 12 15 23">
<original>R</original>
<variation>C</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33973337." id="VAR_025206" evidence="23">
<original>T</original>
<variation>S</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33980385." id="VAR_025207" evidence="23">
<original>D</original>
<variation>G</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34284776." id="VAR_033819">
<original>R</original>
<variation>P</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33926104." id="VAR_025208" evidence="23">
<original>R</original>
<variation>S</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*11; dbSNP:rs35303484." id="VAR_023564" evidence="13">
<original>M</original>
<variation>V</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*12; dbSNP:rs36060847." id="VAR_023565" evidence="13">
<original>G</original>
<variation>E</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*8 and allele CYP2B6*13; dbSNP:rs12721655." id="VAR_016948" evidence="12 13">
<original>K</original>
<variation>E</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*14; dbSNP:rs35773040." id="VAR_023566" evidence="13">
<original>R</original>
<variation>Q</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3826711." id="VAR_016924" evidence="10 22">
<original>P</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*6, allele CYP2B6*7, allele CYP2B6*9 and allele CYP2B6*13; dbSNP:rs3745274." id="VAR_016925" evidence="6 7 9 10 12 15 22 23">
<original>Q</original>
<variation>H</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*3; dbSNP:rs45482602." id="VAR_016928" evidence="7 9">
<original>S</original>
<variation>R</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*4, allele CYP2B6*6, allele CYP2B6*7 and allele CYP2B6*13; slight decrease in activity; dbSNP:rs2279343." id="VAR_016926" evidence="7 9 15 22 23">
<original>K</original>
<variation>R</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34277950." id="VAR_025209" evidence="23">
<original>N</original>
<variation>K</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34698757." id="VAR_025210" evidence="23">
<original>T</original>
<variation>S</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28399499." id="VAR_024716" evidence="15 23">
<original>I</original>
<variation>T</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*15; dbSNP:rs35979566." id="VAR_023567" evidence="13">
<original>I</original>
<variation>N</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2B6*5 and allele CYP2B6*7; dbSNP:rs3211371." id="VAR_016929" evidence="7 9 10 12 15 23">
<original>R</original>
<variation>C</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAF13602." ref="2" evidence="28">
<original>I</original>
<variation>T</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAF13602." ref="2" evidence="28">
<original>L</original>
<variation>P</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="51"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="64"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="73"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="80"/>
<end position="88"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="105"/>
<end position="108"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="118"/>
<end position="131"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="142"/>
<end position="158"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="168"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="193"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="212"/>
<end position="224"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="230"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="264"/>
<end position="274"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="285"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="318"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="340"/>
<end position="345"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="347"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="375"/>
<end position="377"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="380"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="387"/>
<end position="390"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="392"/>
<end position="396"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="399"/>
<end position="401"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="410"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="432"/>
<end position="434"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="439"/>
<end position="456"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="457"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="473"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="486"/>
<end position="490"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3IBD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QU8"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UFG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10768437"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11243870"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11470993"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11695850"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12642465"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12721789"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12865317"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14551287"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15190123"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15194512"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15469410"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15622315"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20061448"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20639527"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21289075"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21875942"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22909231"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="23" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11695850"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="21289075"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2573390"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11695850"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21289075"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:2615"/>
</source>
</evidence>
<sequence length="491" mass="56278" checksum="B9799164BE8FBF1D" modified="1991-02-01" version="1">MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKYFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPKDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

